Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant gain of 65.32% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -2.31%. Over the past 30 days, the price of SXTC has fallen by 114.83%. And in the last five days, it has surged by 119.90%.
China SXT Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $3.37 on 04/16/24 and the lowest value was $0.30 on 12/20/24.
52-week price history of SXTC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. China SXT Pharmaceuticals Inc’s current trading price is -75.07% away from its 52-week high, while its distance from the 52-week low is 180.00%. The stock’s price range during this period has varied between$0.30 and $3.37. The China SXT Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 27.43 million for the day, a figure considerably higher than their average daily volume of 1.13 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
China SXT Pharmaceuticals Inc (SXTC) has experienced a quarterly rise of 116.49% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.92M and boasts a workforce of 75 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4734, with a change in price of +0.1980. Similarly, China SXT Pharmaceuticals Inc recorded 1,104,428 in trading volume during the last 100 days, posting a change of +30.84%.
SXTC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SXTC stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.02.
SXTC Stock Stochastic Average
As of today, China SXT Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 79.41%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 79.07%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 29.59% and 14.59%, respectively.
